Stanford University
Showing 51-60 of 7,777 Results
-
Steven Adelsheim
Clinical Professor, Psychiatry and Behavioral Sciences
BioSteven Adelsheim, MD is a child and adolescent psychiatrist and Associate Chair for
Community Engagement in Stanford’s Department of Psychiatry, where he directs the Center for
Youth Mental Health and Wellbeing. A national leader in early intervention, Dr. Adelsheim
spearheaded the launch of allcove—a youth-driven, integrated mental health model now
expanding across California. He also co-leads PEPPNET, the national early psychosis clinical
network. His work extends to youth suicide prevention, school mental health systems, and
partnerships with Indigenous communities to strengthen culturally grounded early intervention
for tribal youth. Dr. Adelsheim’s career is grounded in building equitable, accessible mental
health systems for young people nationwide. -
Farzana Tabitha Adjah
Assistant Professor of Education
On Leave from 10/01/2025 To 06/30/2026BioDr. Adjah is an Assistant Professor in the Graduate School of Education at Stanford University. She earned her PhD in Clinical-Community Psychology from the George Washington University and completed an APA accredited internship, with a specialization in trauma, at Children’s Hospital Los Angeles. Dr. Adjah’s research examines the influence of racial stressors and culturally relevant practices on the psychological health, academic success, and well-being of Black adolescents and other youth of color. Dr. Adjah uses a strengths-focused and community-based lens in her research to study contextual nuance in the process and benefits of ethnic-racial socialization. She also explores factors in the family, school, and community contexts that can help youth manage the consequences of racial stress and trauma. Her current studies examine the utilization and benefits of ethnic-racial socialization across the school ecology. Dr. Adjah uses her research in each of these areas to inform the development and adaptation of programs and school-based interventions focused on managing racial stressors, eradicating mental health and academic racial disparities, and promoting resilience among historically marginalized and racially diverse children and adolescents. Dr. Adjah is a visiting scholar to the American Psychological Association RESilience Initiative and serves in other positions focused on inclusion, equity and social justice. Prior to coming to Stanford, Dr. Adjah was a Ford Foundation Postdoctoral Fellow and a University of California Chancellor’s Postdoctoral Fellow at the University of California Los Angeles in the Graduate School of Education and Information Studies and the Semel Institute for Neuroscience and Human Behavior, with affiliation in the Ralph J. Bunche Center for African American Studies.
-
John R. Adler, MD
The Dorothy and Thye King Chan Professor in Neurosurgery, Emeritus
Current Research and Scholarly InterestsThe development and implementation of computerized, image-guided surgical tools to be used during minimally invasive brain operations. The clinical outcome of new technologies, and in particular the application of radiosurgery, for the treatment of brain tumors. The creation of new radiosurgical techniques for a wide array of brain and spine disorders.
-
Sarah Adler
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.
-
Shehla Admani, MD
Clinical Associate Professor, Dermatology
BioShehla Admani is a Clinical Assistant Professor of Dermatology at Stanford University, School of Medicine. Dr. Admani completed her dermatology residency at the University California, San Diego where she served as chief resident during her final year. She then completed her pediatric dermatology fellowship at Stanford University, School of Medicine and has stayed on as faculty since that time. She is board certified in dermatology and pediatric dermatology. Dr. Admani’s academic interests include pediatric dermatology, vulvar dermatology and teledermatology.
-
Bruce T. Adornato
Adjunct Clinical Professor, Adult Neurology
BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.
-
Rochael Soper Adranly
Lecturer
BioRochael Soper Adranly is a former Partner and Executive Director, Ventures at IDEO. She is a graduate of Duke Law School and practiced as a commercial attorney with Fulbright & Jaworski in New York and Wilson, Sonsini in Palo Alto, CA. She served as General Counsel & Chief Legal Officer at IDEO for 15 years. She has been a lecturer at UC Berkeley Law, an adjunct professor at UC Law San Francisco, a guest lecturer at Duke University School of Law and a visiting professor at Harvard Law School where she taught Law, Justice and Design. She is also co-owner of Ikaros Greek Restaurant in Oakland, CA. Rochael is an angel investor, notably with investments in Another Tomorrow and Greenwood Bank. She is an artist in her own right with works in photography, writing, documentary filmmaking and visual art (drawing, pen & ink and acrylic painting).
-
Ranjana Advani
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly InterestsClinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
